Optimer Pharmaceuticals (OPTR)
Optimer Pharmaceuticals Balance Sheet
- Quarterly: March 2012 - December 2009 Previous Quarters
- Annual
| Assets | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Cash & Short Term Investments | 71.01M | 110.58M | 129.36M | 157.79M | 180.10M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Receivables | 58.84M | 58.85M | 7.996M | 0.079M | 1.655M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Inventory | 5.869M | 3.947M | 2.245M | 1.370M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Prepaid Expenses | 2.684M | 3.782M | 3.569M | 5.844M | 0.9753M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Current Assets | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Total Current Assets | 138.40M | 177.16M | 143.17M | 165.09M | 182.73M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Gross Property, Plant & Equipment | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Accumulated Depreciation | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Net Property, Plant & Equipment | 3.419M | 2.591M | 2.067M | 2.172M | 0.864M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Long Term Investments | 30.10M | 0.882M | 0.882M | 0.882M | 0.882M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Goodwill & Intangibles | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Long Term Assets | 1.425M | 1.390M | 1.390M | 1.242M | 0.7919M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Long Term Assets | 34.94M | 4.862M | 4.339M | 4.297M | 2.538M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Assets | 173.34M | 182.02M | 147.51M | 169.38M | 185.26M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Liabilities | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Current Portion of Long Term Debt | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Accounts Payable | 7.810M | 9.860M | 6.305M | 6.738M | 5.169M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Accrued Expenses | 27.99M | 21.45M | 8.800M | 5.081M | 3.126M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Deferred Revenues | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Current Liabilities | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Total Current Liabilities | 35.80M | 31.31M | 15.11M | 11.82M | 8.295M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Long Term Debt | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Shareholder's Equity | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Deferred Income Tax | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Minority Interest | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Long Term Liabilities | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Total Long Term Liabilities | 0.1482M | 0.1511M | 0.1633M | 0.1835M | 0.1342M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Liabilities | 35.95M | 31.46M | 15.27M | 12.00M | 8.429M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Common Shares Outstanding | 46.76M | 46.69M | 46.65M | 46.60M | 46.28M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Preferred Stock | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Common Stock, Net | 0.0468M | 0.0467M | 0.0466M | 0.0466M | 0.0463M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Additional Paid-in Capital | 362.29M | 358.90M | 354.06M | 351.22M | 346.03M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Retained Earnings | -225.91M | -214.99M | -228.35M | -201.92M | -177.68M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Treasury Stock | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Shareholder's Equity | 0.00 | 6.661M | 6.742M | 7.495M | 8.160M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Shareholder's Equity | 137.39M | 150.56M | 132.24M | 157.38M | 176.83M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Liabilities & Shareholder's Equity | 173.34M | 182.02M | 147.51M | 169.38M | 185.26M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |